Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inherited C1 inhibitor deficiency.

A Agostoni1

  • 1Clinica Medica V, Ospedale S. Paolo, Università degli Studi di Milano, Italia.

Complement and Inflammation
|January 1, 1989
PubMed
Summary

This study followed 179 hereditary angioedema (HAE) patients for 15 years, detailing disease variants, attack patterns, and genetic links. Findings inform HAE management and prophylaxis strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The kinin system: biological mechanisms and clinical implications].

Recenti progressi in medicina·2002
Same author

Increase of bradykinin in plasma of patients undergoing cardiopulmonary bypass: the importance of lung exclusion.

Chest·2001
Same author

Bradykinin in the ascitic fluid of patients with liver cirrhosis.

Clinical science (London, England : 1979)·2001
Same author

Drug-induced angioedema without urticaria.

Drug safety·2001
Same author

In vitro interaction of C1-inhibitor with thrombin.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2001
Same author

Influence of contact system deficiencies during cardiopulmonary bypass.

Thrombosis and haemostasis·2001

Area of Science:

  • Immunology
  • Genetics
  • Clinical Medicine

Background:

  • Hereditary angioedema (HAE) is an autosomal dominant disorder.
  • Two main types exist: Type I (C1-inhibitor deficiency) and Type II (normal C1-INH antigen, absent function).
  • Characterized by recurrent swelling in subcutaneous and mucous tissues.

Purpose of the Study:

  • To report a 15-year follow-up experience with 179 HAE patients.
  • To analyze HAE attack characteristics (frequency, location, triggers).
  • To investigate genetic factors and present prophylaxis/treatment data.

Main Methods:

  • Longitudinal follow-up of 179 HAE patients over 15 years.
  • Clinical data collection on attack patterns and triggers.
  • Genomic DNA analysis using C1-inhibitor cDNA probe for genetic polymorphisms.

Main Results:

  • Detailed frequency, localization, and triggering factors of HAE attacks were documented.
  • Genetic analysis revealed linkage of RFLPs to HAE in a subset of patients.
  • Experience with prophylaxis and treatment strategies for HAE attacks is presented.

Conclusions:

  • The study provides valuable long-term clinical insights into hereditary angioedema.
  • Genetic analysis suggests potential markers for HAE.
  • Findings support current approaches to HAE prophylaxis and treatment.

Related Experiment Videos